Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors

[1]  Chad W. Euler,et al.  Evolution of Autoantibody Responses via Somatic Hypermutation Outside of Germinal Centers , 2002, Science.

[2]  D. Golenbock,et al.  Cutting Edge: Immune Stimulation by Neisserial Porins Is Toll-Like Receptor 2 and MyD88 Dependent1 , 2002, The Journal of Immunology.

[3]  R. Medzhitov,et al.  TIRAP: an adapter molecule in the Toll signaling pathway , 2001, Nature Immunology.

[4]  A. Krieg,et al.  CpG stimulation of primary mouse B cells is blocked by inhibitory oligodeoxyribonucleotides at a site proximal to NF-kappaB activation. , 2001, Antisense & nucleic acid drug development.

[5]  S. Akira,et al.  Toll-like receptors: critical proteins linking innate and acquired immunity , 2001, Nature Immunology.

[6]  Amer A. Beg,et al.  An Essential Role of the NF-κB/Toll-Like Receptor Pathway in Induction of Inflammatory and Tissue-Repair Gene Expression by Necrotic Cells1 , 2001, The Journal of Immunology.

[7]  R. Scott,et al.  Phagocytosis and clearance of apoptotic cells is mediated by MER , 2001, Nature.

[8]  S. Akira,et al.  A Toll-like receptor recognizes bacterial DNA , 2000, Nature.

[9]  S. Akira,et al.  Immune Cell Activation by Bacterial Cpg-DNA through Myeloid Differentiation Marker 88 and Tumor Necrosis Factor Receptor–Associated Factor (Traf)6 , 2000, The Journal of experimental medicine.

[10]  M. Shlomchik,et al.  Immune Complexes Present in the Sera of Autoimmune Mice Activate Rheumatoid Factor B Cells1 , 2000, The Journal of Immunology.

[11]  T. Möröy,et al.  Features of systemic lupus erythematosus in Dnase1-deficient mice , 2000, Nature Genetics.

[12]  S. Strober,et al.  Cutting Edge: A Role for CD1 in the Pathogenesis of Lupus in NZB/NZW Mice1 , 2000, The Journal of Immunology.

[13]  M. Shlomchik,et al.  Autoantigen-Specific B Cell Activation in FAS-Deficient Rheumatoid Factor Immunoglobulin Transgenic Mice , 1999, The Journal of experimental medicine.

[14]  S. Akira,et al.  Unresponsiveness of MyD88-deficient mice to endotoxin. , 1999, Immunity.

[15]  P. Butler,et al.  Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity , 1999, Nature Medicine.

[16]  M. Weisman,et al.  Dose-loading with hydroxychloroquine improves the rate of response in early, active rheumatoid arthritis: a randomized, double-blind six-week trial with eighteen-week extension. , 1999, Arthritis and rheumatism.

[17]  H. Mischak,et al.  CpG‐DNA‐specific activation of antigen‐presenting cells requires stress kinase activity and is preceded by non‐specific endocytosis and endosomal maturation , 1998, The EMBO journal.

[18]  S. Akira,et al.  Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. , 1998, Immunity.

[19]  A. Krieg,et al.  CpG motifs in bacterial DNA activate leukocytes through the pH-dependent generation of reactive oxygen species. , 1998, Journal of immunology.

[20]  Pier Paolo Pandolfi,et al.  Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies , 1998, Nature Genetics.

[21]  C. Janeway,et al.  A human homologue of the Drosophila Toll protein signals activation of adaptive immunity , 1997, Nature.

[22]  D. Fearon.  Seeking wisdom in innate immunity , 1997, Nature.

[23]  M. Shlomchik,et al.  A disease-related rheumatoid factor autoantibody is not tolerized in a normal mouse: implications for the origins of autoantibodies in autoimmune disease , 1996, The Journal of experimental medicine.

[24]  J. Ahearn,et al.  Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. , 1996, Immunity.

[25]  H. Ploegh,et al.  How MHC class II molecules reach the endocytic pathway. , 1995, The EMBO journal.

[26]  M. Shlomchik,et al.  An isotype switched and somatically mutated rheumatoid factor clone isolated from a MRL-lpr/lpr mouse exhibits limited intraclonal affinity maturation. , 1994, Journal of immunology.

[27]  M. Shlomchik,et al.  A rheumatoid factor transgenic mouse model of autoantibody regulation. , 1993, International immunology.

[28]  V. Holers,et al.  Regulation of nuclear antigen expression on the cell surface of human monocytes. , 1992, Journal of immunology.

[29]  D. Bell,et al.  The spontaneous apoptotic cell death of normal human lymphocytes in vitro: the release of, and immunoproliferative response to, nucleosomes in vitro. , 1991, Clinical immunology and immunopathology.

[30]  D. Bell,et al.  Immunogenic DNA-related factors. Nucleosomes spontaneously released from normal murine lymphoid cells stimulate proliferation and immunoglobulin synthesis of normal mouse lymphocytes. , 1990, The Journal of clinical investigation.

[31]  D. Fearon,et al.  Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes. , 1988, Journal of immunology.

[32]  A. Marshak‐Rothstein,et al.  Oligoclonality of rheumatoid factors arising spontaneously in lpr/lpr mice. , 1988, Clinical immunology and immunopathology.

[33]  R. Balderas,et al.  Association of lpr gene with graft-vs.-host disease-like syndrome , 1985, The Journal of experimental medicine.

[34]  G. Möller,et al.  Lipopolysaccharides can convert heterologous red cells into thymus-independent antigens. , 1972, Cellular immunology.

[35]  M. Monestier,et al.  Specificities and genetic characteristics of nucleosome-reactive antibodies from autoimmune mice. , 1996, Molecular immunology.

[36]  E. Tan,et al.  Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. , 1989, Advances in immunology.

[37]  Thomas L. Rothstein,et al.  The role of clonal selection and somatic mutation in autoimmunity , 1987, Nature.